ATProto Browser

Record data

{
  "uri": "at://did:plc:sij7wzttoxd3ujhhnptqb3c5/app.bsky.feed.post/3lo4jepbbok2f",
  "cid": "bafyreidyruutggkl6wsk7wnepmbxqkgu5zvh3em3lxyk2vxgmgumukgpf4",
  "value": {
    "text": "Breakthrough Therapy Designation granted by FDA to AMT-130 for Huntington's Diease, now in Phase 1 and 2 research. Early days, but hopeful. #Medsdky www.pharmacytimes.com/view/fda-gra...",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.pharmacytimes.com/view/fda-grants-breakthrough-therapy-designation-to-amt-130-to-treat-huntington-disease?ekey=RUtJRDo3OUFBNUM5NS1ENUVFLTRCNDEtQjQ1Qy0xN0ZEQjMxQUI0NzQ%3D&_hsmi=359067701",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreifou7uwulunprr5jukcekzetd5marn4umb5s2dwh4uaigutwjcj6a"
          },
          "mimeType": "image/jpeg",
          "size": 675802
        },
        "title": "FDA Grants Breakthrough Therapy Designation to AMT-130 to Treat Huntington Disease",
        "description": "The breakthrough designation is supported by clinical data from ongoing phase 1/2 trials."
      }
    },
    "langs": [
      "en"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 148,
          "byteStart": 140
        },
        "features": [
          {
            "tag": "Medsdky",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 186,
          "byteStart": 149
        },
        "features": [
          {
            "uri": "https://www.pharmacytimes.com/view/fda-grants-breakthrough-therapy-designation-to-amt-130-to-treat-huntington-disease?ekey=RUtJRDo3OUFBNUM5NS1ENUVFLTRCNDEtQjQ1Qy0xN0ZEQjMxQUI0NzQ%3D&_hsmi=359067701",
            "$type": "app.bsky.richtext.facet#link"
          }
        ]
      }
    ],
    "createdAt": "2025-05-01T14:27:28.314Z"
  }
}